These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26307705)

  • 21. Protective effects of hydroxytyrosol against α-synuclein toxicity on PC12 cells and fibril formation.
    Hornedo-Ortega R; Cerezo AB; Troncoso AM; Garcia-Parrilla MC
    Food Chem Toxicol; 2018 Oct; 120():41-49. PubMed ID: 29964084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
    Rekas A; Ahn KJ; Kim J; Carver JA
    Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of a single α-synuclein fibrillation by the interaction with a protein nanopore.
    Wang HY; Gu Z; Cao C; Wang J; Long YT
    Anal Chem; 2013 Sep; 85(17):8254-61. PubMed ID: 23899046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation.
    Binolfi A; Lamberto GR; Duran R; Quintanar L; Bertoncini CW; Souza JM; Cerveñansky C; Zweckstetter M; Griesinger C; Fernández CO
    J Am Chem Soc; 2008 Sep; 130(35):11801-12. PubMed ID: 18693689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State.
    Kurnik M; Sahin C; Andersen CB; Lorenzen N; Giehm L; Mohammad-Beigi H; Jessen CM; Pedersen JS; Christiansen G; Petersen SV; Staal R; Krishnamurthy G; Pitts K; Reinhart PH; Mulder FAA; Mente S; Hirst WD; Otzen DE
    Cell Chem Biol; 2018 Nov; 25(11):1389-1402.e9. PubMed ID: 30197194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibril breaking accelerates α-synuclein fibrillization.
    Shvadchak VV; Claessens MM; Subramaniam V
    J Phys Chem B; 2015 Feb; 119(5):1912-8. PubMed ID: 25582977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of an N-methylated peptide inhibitor of alpha-synuclein aggregation guided by solid-state NMR.
    Madine J; Doig AJ; Middleton DA
    J Am Chem Soc; 2008 Jun; 130(25):7873-81. PubMed ID: 18510319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Detergent on α-Synuclein Structure. A Native MS-Ion Mobility Study.
    Moons R; van der Wekken-de Bruijne R; Maudsley S; Lemière F; Lambeir AM; Sobott F
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1.
    Lee JH; Lee IH; Choe YJ; Kang S; Kim HY; Gai WP; Hahn JS; Paik SR
    Biochem J; 2009 Mar; 418(2):311-23. PubMed ID: 19007333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemin as a generic and potent protein misfolding inhibitor.
    Liu Y; Carver JA; Ho LH; Elias AK; Musgrave IF; Pukala TL
    Biochem Biophys Res Commun; 2014 Nov; 454(2):295-300. PubMed ID: 25450392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.
    Ghee M; Melki R; Michot N; Mallet J
    FEBS J; 2005 Aug; 272(16):4023-33. PubMed ID: 16098186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
    Luk KC; Hyde EG; Trojanowski JQ; Lee VM
    Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking.
    Konno T; Morii T; Hirata A; Sato S; Oiki S; Ikura K
    Biochemistry; 2005 Feb; 44(6):2072-9. PubMed ID: 15697232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide ligand screening of alpha-synuclein aggregation modulators by in silico panning.
    Abe K; Kobayashi N; Sode K; Ikebukuro K
    BMC Bioinformatics; 2007 Nov; 8():451. PubMed ID: 18005454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of small molecules in modulating the chaperone activity of alphaB-crystallin against ordered and disordered protein aggregation.
    Ecroyd H; Carver JA
    FEBS J; 2008 Mar; 275(5):935-47. PubMed ID: 18218039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry.
    Young LM; Saunders JC; Mahood RA; Revill CH; Foster RJ; Tu LH; Raleigh DP; Radford SE; Ashcroft AE
    Nat Chem; 2015 Jan; 7(1):73-81. PubMed ID: 25515893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactivity profiling with parallel mass spectrometry reveals an assemblage of green tea metabolites affording protection against human huntingtin and alpha-synuclein toxicity.
    Williams RB; Gutekunst WR; Joyner PM; Duan W; Li Q; Ross CA; Williams TD; Cichewicz RH
    J Agric Food Chem; 2007 Nov; 55(23):9450-6. PubMed ID: 17944533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of alpha-synuclein.
    Binolfi A; Rodriguez EE; Valensin D; D'Amelio N; Ippoliti E; Obal G; Duran R; Magistrato A; Pritsch O; Zweckstetter M; Valensin G; Carloni P; Quintanar L; Griesinger C; Fernández CO
    Inorg Chem; 2010 Nov; 49(22):10668-79. PubMed ID: 20964419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A routinely used protein staining dye acts as an inhibitor of wild type and mutant alpha-synuclein aggregation and modulator of neurotoxicity.
    Ahsan N; Siddique IA; Gupta S; Surolia A
    Eur J Med Chem; 2018 Jan; 143():1174-1184. PubMed ID: 29150334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.